关键数据
13.770今开
13.970最高
2.01K成交量
亏损市盈率 TTM
亏损市盈率动
--股息TTM
0.02%换手率
13.650昨收
13.330最低
27.72K成交额
亏损市盈率静
3.99市净率
0.00%股息率 TTM
-29.90%ROA
20.03052周最高
0.03量比
-30.22M净利润
12.85M总股本
-2.0990每股收益TTM
0.18Beta
-52.35%ROE
12.52052周最低
4.69%振幅
10.90%毛利率
177.72M总市值
-2.91回报/风险
2.51%风险率

即将为您带来更多新闻,敬请期待。。。
Mediwound Ltd评分
-0.05与上次评分对比预测8.33
财务诊断7.39
技术分析3.26
公司估值7.53
机构认同度5.00
风险评估5.72
分析师评级
买入评级
30.667目标均价
+124.66%涨幅空间
Mediwound Ltd 最新财报电话会记录
MediWound (MDWD) 2026年第二季度业绩电话会:VALU按计划推进,重申业绩指引
MediWound 2026年第二季度营收降至310万美元,随着VALU试验入组按计划推进,管理层重申了2400万至2600万美元的业绩指引。
财务指标
货币: USD

由于公司未披露,未能获取相关数据
货币: USD

由于公司未披露,未能获取相关数据
Mediwound Ltd 简介
Mediwound Ltd is an Israel-based biopharmaceutical company that develops, manufactures and commercializes novel, cost effective, bio-therapeutic solutions for tissue repair and regeneration. Company's portfolio is focused on next-generation protein-based therapies for burn and wound care and tissue repair and includes products such as, NexoBrid, a concentrate of proteolytic enzymes enriched in bromelain, which is an easy to use, topically-applied product that removes eschar in four hours without harming the surrounding healthy tissues.; EscharEx biological drug candidate for the debridement of chronic and other hard-to-heal wounds; MW005 a topically applied biological drug candidate for the treatment of non-melanoma skin cancers, based on the same API of NexoBrid and EscharEx products, a concentrate of proteolytic enzymes enriched in bromelain.
行业药品
公司代码MDWD
员工数量111
国家Israel
持股情况
| 持股股东 | 占比 |
|---|
| Clal Biotechnology Industries Ltd | 11.53% |
|---|
| HOLD Alapkezelo Zrt | 8.09% |
|---|
| Investor AB | 6.79% |
|---|
| Yelin Lapidot Provident Funds Management Ltd | 5.94% |
|---|
| 股东类型 | 占比 |
|---|
| Investment Advisor | 27.02% |
|---|
| Holding Company | 11.53% |
|---|
| Investment Advisor/Hedge Fund | 11.31% |
|---|
| Hedge Fund | 10.41% |
|---|
常见问题
Mediwound Ltd(MDWD)的当前股价是多少?
Mediwound Ltd(MDWD)的当前股价是 13.65。
Mediwound Ltd股票的52周最高点是多少?
Mediwound Ltd股票的52周最高点是20.03。
Mediwound Ltd股票的52周最低点是多少?
Mediwound Ltd股票的52周最低点是12.52。
Mediwound Ltd的市值是175.40M。
现在Mediwound Ltd(MDWD)的股票是买入、持有还是卖出?
根据分析师评级,Mediwound Ltd(MDWD)的总体评级为买入,目标价格为30.67。
Mediwound Ltd(MDWD)股票的每股收益(EPS TTM)是多少
Mediwound Ltd(MDWD)股票的每股收益(EPS TTM)是-2.10。